1. Home
  2. MBRX vs AMZE Comparison

MBRX vs AMZE Comparison

Compare MBRX & AMZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBRX
  • AMZE
  • Stock Information
  • Founded
  • MBRX 2015
  • AMZE 2019
  • Country
  • MBRX United States
  • AMZE United States
  • Employees
  • MBRX N/A
  • AMZE N/A
  • Industry
  • MBRX Biotechnology: Pharmaceutical Preparations
  • AMZE Beverages (Production/Distribution)
  • Sector
  • MBRX Health Care
  • AMZE Consumer Staples
  • Exchange
  • MBRX Nasdaq
  • AMZE Nasdaq
  • Market Cap
  • MBRX 17.1M
  • AMZE 16.1M
  • IPO Year
  • MBRX 2016
  • AMZE 2021
  • Fundamental
  • Price
  • MBRX $0.38
  • AMZE $1.89
  • Analyst Decision
  • MBRX Strong Buy
  • AMZE
  • Analyst Count
  • MBRX 4
  • AMZE 0
  • Target Price
  • MBRX $5.00
  • AMZE N/A
  • AVG Volume (30 Days)
  • MBRX 4.0M
  • AMZE 80.7K
  • Earning Date
  • MBRX 11-07-2025
  • AMZE 08-14-2025
  • Dividend Yield
  • MBRX N/A
  • AMZE N/A
  • EPS Growth
  • MBRX N/A
  • AMZE N/A
  • EPS
  • MBRX N/A
  • AMZE N/A
  • Revenue
  • MBRX N/A
  • AMZE $1,054,111.00
  • Revenue This Year
  • MBRX N/A
  • AMZE $6,741.66
  • Revenue Next Year
  • MBRX N/A
  • AMZE $100.61
  • P/E Ratio
  • MBRX N/A
  • AMZE N/A
  • Revenue Growth
  • MBRX N/A
  • AMZE N/A
  • 52 Week Low
  • MBRX $0.25
  • AMZE $1.57
  • 52 Week High
  • MBRX $3.65
  • AMZE $28.72
  • Technical
  • Relative Strength Index (RSI)
  • MBRX 32.94
  • AMZE 27.92
  • Support Level
  • MBRX $0.35
  • AMZE $2.35
  • Resistance Level
  • MBRX $0.62
  • AMZE $2.71
  • Average True Range (ATR)
  • MBRX 0.05
  • AMZE 0.31
  • MACD
  • MBRX -0.02
  • AMZE 0.04
  • Stochastic Oscillator
  • MBRX 8.19
  • AMZE 16.16

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

About AMZE Amaze Holdings Inc. Common Stock

Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.

Share on Social Networks: